Send Enquiry

AUSPIN
Tablets
Packaging and packing Type
Blister | 10x15
MRP :
₹122
PTR :
₹92.95
PTS :
₹83.66
Prescription medicine Read More
Composition
Send Enquiry
India’s Trusted Pharma Brand
100%
Genuine Products
Secure
Payments
24 x 7
Customer Support
About the product
By Vibcare Pharma · Updated 9 October 2026 · Based on product labels and standard drug references
Jempoglim M1 is an anti-diabetic tablet from the Auspin division of Vibcare Pharma. The composition in each tablet is Glimepiride 1 mg and Metformin 500 mg. Pack size for the product is 10x15 (Blister).
Two different roles are at work here. Glimepiride acts on the pancreas and pushes it to release insulin, which lowers the glucose in the bloodstream. Metformin, meanwhile, cuts down the glucose produced by the liver and improves the action of insulin in the body's tissues. Taken together, the two ingredients complement each other in lowering blood glucose.
The tablets are used to improve glycemic control in adults with type 2 diabetes mellitus, along with diet and exercise. Severe hypoglycemia is a known risk of glimepiride and calls for care in elderly or renally impaired patients and with other anti-diabetic drugs. Metformin carries a risk of lactic acidosis, mainly in kidney impairment, heavy alcohol use, dehydration, liver disease, contrast scans, surgery or low-oxygen states.
Use only on a doctor's prescription, at the dose and for the duration advised.
Common
Get medical help at once if you notice
Do not use
Ask a doctor first
Jempoglim M1 tablets contain Glimepiride 1 mg and Metformin 500 mg and are used with diet and exercise in type 2 diabetes. Main uses: used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus; helps lower blood glucose by two different actions in the body.
Common side effects of Jempoglim M1 Tablet include low blood sugar (hypoglycemia); headache; nausea; dizziness; weakness (asthenia); diarrhoea and stomach upset. Get medical help at once if you notice severe hypoglycemia; lactic acidosis (rare but serious, linked to metformin); hemolytic anemia in patients with G6PD deficiency.
Each Jempoglim M1 tablet contains Glimepiride 1 mg + Metformin 500 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Jempoglim M1 Tablet only as your doctor advises.
The MRP of Jempoglim M1 Tablet is ₹122 for a pack of 10x15 (Blister). For chemists and distributors, the PTR is ₹92.95 and the PTS is ₹83.66.
Each Jempoglim M1 tablet contains Glimepiride 1 mg + Metformin 500 mg. It comes in a pack of 10x15 (Blister).
Two different roles are at work here. Glimepiride acts on the pancreas and pushes it to release insulin, which lowers the glucose in the bloodstream. Metformin, meanwhile, cuts down the glucose produced by the liver and improves the action of insulin in the body's tissues. Taken together, the two ingredients complement each other in lowering blood glucose.
Must not be used for type 1 diabetes mellitus or diabetic ketoacidosis. Must not be used in severe renal impairment (eGFR below 30 mL/min/1.73 m²) or in metabolic acidosis. Must not be used by anyone allergic to glimepiride, sulphonamide derivatives, metformin or any ingredient of the tablet. Check with a doctor first if the patient is elderly, has kidney or liver problems, drinks alcohol heavily, is dehydrated, or is going for a scan with contrast dye, surgery or other procedures. Check with a doctor first if the patient takes insulin or other blood sugar lowering medicines, or has G6PD deficiency.
Jempoglim M1 Tablet is a brand of Vibcare Pharma, sold through its Auspin division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.
Similar Products
Send Enquiry
Request a callback to get more information about becoming a PCD Franchise Owner